'THE STORY OF EVERYTHING' PRESENTS GROUNDBREAKING EVIDENCE THAT HAS REIGNITED THE DEBATE OVER SCIENCE, ORIGINS, AND THE EXISTENCE OF GOD IN THEATRES NATIONWIDE FROM FATHOM ENTERTAINMENT APRIL 30-MAY 6

Rhea-AI Summary

The Story of Everything is a new feature documentary opening in theatres nationwide April 30–May 6, distributed by Fathom Entertainment. The film presents arguments for Intelligent Design featuring Dr. Stephen C. Meyer, Jay W. Richards, and executive producer Lee Strobel, with tickets on sale March 13, 2026.

The release credits Discovery Institute support and notes Fathom is owned by AMC (NYSE:AMC), Cinemark (NYSE:CNK), and Regal Cineworld Group.

News Market Reaction – AMC

+4.42%

1 alert

+4.42% News Effect

+$27M Valuation Impact

$636M Market Cap

0.4x Rel. Volume

On the day this news was published, AMC gained 4.42%, reflecting a moderate positive market reaction. This price movement added approximately $27M to the company's valuation, bringing the market cap to $636M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Theatrical run dates: April 30–May 6, 2026 Ticket on-sale date: March 13, 2026 Discovery Institute founding: 1991 +5 more

8 metrics

Theatrical run dates April 30–May 6, 2026 Fathom Entertainment engagement for 'The Story of Everything'

Ticket on-sale date March 13, 2026 Tickets available via Fathom Entertainment and theatres

Discovery Institute founding 1991 Year Discovery Institute was founded

Media interviews Over 290 Center for Science and Culture media interviews in 2025

Social followers More than 630,000 Discovery Institute Center social subscribers, friends, followers

Social media views More than 117 million Discovery Institute Center social media views in 2025

Social actions 4.3 million+ Actions on social media posts in 2025

Fathom operating history More than 20 years Fathom Entertainment’s track record as a specialty distributor

Market Reality Check

Price: $1.18 Vol: Volume 29,592,705 is 0.76...

normal vol

$1.18 Last Close

Volume Volume 29,592,705 is 0.76x the 20-day average of 38,804,450, suggesting quieter trading ahead of this content news. normal

Technical Shares at $1.12 trade 72.55% below the 52-week high of $4.08 and only 1.82% above the 52-week low of $1.10, remaining below the $2.50 200-day MA.

Peers on Argus

AMC slipped 0.88% while key peers were mixed: IMAX (-1.06%), HUYA (-1.42%), SPHR...

1 Up

AMC slipped 0.88% while key peers were mixed: IMAX (-1.06%), HUYA (-1.42%), SPHR (-0.74%) versus PLAY (+6.59%) and MCS (+5.98%). Momentum scanners only flagged RSVR (+12.78%) with no news, reinforcing this as company-specific content exposure rather than a broad theater-sector move.

Historical Context

5 past events · Latest: Feb 26 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 26	Earnings release	Positive	+1.8%	National CineMedia reported revenue growth and positive operating income for Q4 and FY 2025.
Feb 23	Debt financing	Neutral	-4.2%	AMC announced large first lien notes and term loan financing tied to refinancing plans.
Feb 23	Earnings posting	Neutral	-4.2%	AMC posted Q4 and full-year 2025 results and scheduled an investor webcast.
Feb 19	Earnings date set	Neutral	-1.6%	National CineMedia set its Q4 and FY 2025 earnings release and call date.
Jan 29	Refinancing & preview	Positive	-4.2%	AMC gained refinancing flexibility and previewed higher Q4 and FY 2025 revenue and EBITDA.

Pattern Detected

Recent AMC-related headlines around debt refinancing and earnings often saw negative price reactions, even when news carried constructive elements.

Recent Company History

Over recent months, related cinema and AMC-specific news showed mixed but often negative price follow-through. A refinancing agreement and preliminary Q4 2025 results on Jan 29 were followed by a -4.2% move. Subsequent first-lien notes and term loan financing details on Feb 23, plus full earnings posting, coincided with another -4.17% reaction. By contrast, National CineMedia’s Q4 2025 results on Feb 26 produced a modest +1.75% move, showing that solid fundamentals at peers can be rewarded despite AMC’s own pressure. Today’s film-event announcement fits the broader content/distribution narrative rather than capital-structure themes.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2026-02-09

AMC filed an automatic shelf registration on Feb 9, 2026 on Form S-3ASR, allowing the company and certain selling stockholders to offer various securities, including Class A common stock, preferred stock, depositary shares, warrants and units. Potential uses include refinancing or repaying debt, working capital and capital investments. The filing highlights risks from high leverage, liquidity pressure, evolving distribution practices and potential further equity dilution.

Market Pulse Summary

This announcement highlights AMC’s exposure to event-style content via Fathom Entertainment, which i...

Analysis

This announcement highlights AMC’s exposure to event-style content via Fathom Entertainment, which is releasing a science-focused faith documentary in theatres April 30–May 6. It reinforces AMC’s use of alternative programming beyond traditional studio releases. Against a backdrop of recent refinancing efforts and an effective S-3ASR shelf, investors may watch how such specialty events affect box office trends, utilization of the shelf for funding flexibility, and progress on debt reduction and liquidity over time.

Key Terms

cosmology, molecular biology, dna

3 terms

cosmology technical

"stunning new evidence from cosmology, physics, and molecular biology"

Cosmology is the scientific study of the universe’s origin, large‑scale structure, and long‑term evolution. For investors, it matters because discoveries and the technology developed to explore cosmological questions—like advanced sensors, data processing, and satellites—can create new markets, influence government funding priorities, and drive long‑term innovation much like how basic research in other fields led to practical products years later.

molecular biology medical

"stunning new evidence from cosmology, physics, and molecular biology"

The study of how the tiny parts inside cells—like DNA, RNA and proteins—work together to build and run living things. Think of it as reading a blueprint and watching the construction crew at the same time: it explains how biological processes are coded and carried out. Investors care because discoveries and techniques in molecular biology drive new drugs, diagnostics and tests, shaping the potential value, development timelines and regulatory risks of life‑science companies.

dna medical

"research into the fine-tuning of physical laws and the information encoded in DNA"

DNA is the molecule that carries the genetic instructions for living organisms—think of it as a biological blueprint or instruction manual for cells. For investors, DNA matters because many medical tests, biotech treatments, and diagnostic products depend on reading, modifying or targeting these instructions; breakthroughs, patents, regulatory approvals, or safety issues tied to DNA-based technologies can drive a company’s revenue, costs and risk profile much like a key engine part determines a car’s performance.

AI-generated analysis. Not financial advice.

From the Team Behind 'When Calls the Heart' and 'After Death,' the Discovery Institute–Backed Feature Launches Its Official Trailer

Lee Strobel Boards as Executive Producer on Science-Driven Documentary Featuring Dr. Stephen C. Meyer and Jay W. Richards

NASHVILLE, Tenn. and DENVER, March 4, 2026 /PRNewswire/ -- A new feature documentary is about to challenge everything you thought science had settled about the origin of the universe—and the existence of God. The Story of Everything arrives in theatres nationwide April 30–May 6 from Fathom Entertainment, the leading specialty distributor of content to theatrical partners worldwide. The Story of Everything will bring to the big screen stunning new evidence from cosmology, physics, and molecular biology that its creators say demands a radical rethinking of where we came from and why we are here. 

Watch the trailer here.

Produced by Brian Bird (When Calls the Heart) alongside Jason Pamer and Jens Jacob of Sypher Studios (After Death, the #1 grossing faith documentary of all time), the Discovery Institute–backed film takes audiences on a cinematic journey from the star-forming regions of the cosmos to the intricate architecture of living cells—revealing unmistakable signs of intentional design woven throughout nature. 

The film confronts a familiar narrative head-on: that the universe emerged from nothing and that life arose by accident. Drawing on cutting-edge research into the fine-tuning of physical laws and the information encoded in DNA, The Story of Everything makes a bold case that the most significant scientific discoveries of our era do not point away from God—they point directly toward Him. 

Bestselling author and investigative journalist Lee Strobel (The Case for Christ) has joined the project as Executive Producer. Executive Producers Paul and Monica Kepes, who have championed the film throughout its five-year journey, are joined by Executive Producers Karl and Nelda Buckman, and Jef Sewell, who have recently come alongside the project in support of its theatrical release, with Ted Robinson serving as Co-Executive Producer.

"I've spent decades investigating whether belief in God stands up to scrutiny," Strobel said. "What makes The Story of Everything compelling is its focus on scientific evidence and its invitation for audiences to examine the data for themselves." 

Dr. Stephen C. Meyer, a Cambridge University–trained philosopher of science, New York Times bestselling author, and Senior Fellow at the Discovery Institute, anchors the film's scientific exploration. Featured on The Joe Rogan Experience, Dr. Meyer is the Director of the Discovery Institute's Center for Science and Culture, and his book inspired the new film. Additional philosophers and scientists, including Jay W. Richards, John Lennox, Peter Thiel, and more, share groundbreaking discoveries throughout the documentary to further the case for Intelligent Design.

"This film doesn't ask audiences to believe without evidence—it shows them the evidence," said Meyer. "The Story of Everything tells nothing less than the story of the scientific rediscovery of the evidence for the existence of God." 

"The Story of Everything is a cinematic search for the signature behind reality—from the laws that shape galaxies to the code written into every living cell," said director Eric Esau. "We set out to bridge wonder and reason, letting the cosmos and biology speak for themselves. I hope that the film awakens awe at the possibility that the deep order of the universe is not a coincidence, but a clue pointing to a mind behind it all." 

With Bird's large-scale storytelling experience and Pamer's past commercial success, the film brings cinematic scope to one of humanity's oldest questions: Is there a mind behind the universe?

For more information, visit thestoryofeverything.film and follow @storyofeverythingfilm on Facebook, Instagram, TikTok, X, and YouTube. 

Tickets for The Story of Everything will be available on March 13, 2026, at Fathom Entertainment and participating theatre box offices (theatre locations are subject to change). For more information or to be the first to know when tickets are available, visit Fathom Entertainment. 

About Discovery Institute
Founded in 1991 and headquartered in Seattle, Discovery Institute is a non-profit, non-partisan organization focused on research, education, action, and cultural renewal. It brings together a growing global network of scholars, scientists, and policy experts. The Institute investigates the life-changing possibilities of a universe brimming with information and intelligent design. It has a special interest in exploring how science and technology can advance free markets, propel new discoveries, illuminate public policy, and support human dignity and the metaphysical foundations of a free society. The Institute sponsors research in the sciences, humanities, and public policy. It organizes conferences, seminars, and educational programs for both young people and adults. It produces and disseminates books, articles, reports, and a wide array of multimedia content designed to inform the public. Its largest program is the Center for Science and Culture, whose mission is to advance the understanding that human beings and nature are the result of intelligent design rather than a blind and undirected process. The Center seeks long-term scientific and cultural change through cutting-edge scientific research and scholarship; education and training of young leaders; communication to the general public; and advocacy of academic freedom and free speech for scientists, teachers, and students. The Center's experts gave over 290 media interviews in 2025. It has more than 630,000 subscribers, friends, and followers on YouTube, Instagram, X, and Facebook, and its social media posts received more than 117 million views in 2025 and inspired 4.3 million+ actions.

About Fathom Entertainment
Fathom Entertainment is the leading global specialty distributor of content to movie theatres. For more than 20 years, Fathom Entertainment has pioneered theatrical distribution of events and special engagements across various genres and formats, including feature films, episodic content, documentaries, concerts, and live events. Fathom consistently ranks among the top 10 theatrical distributors in North America and distributes content to cinemas worldwide. Fathom Entertainment is owned by AMC Entertainment Inc. (NYSE: AMC), Cinemark Holdings, Inc. (NYSE: CNK), and Regal Cineworld Group (LSE: CINE.L). For more information, visit FathomEntertainment.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-story-of-everything-presents-groundbreaking-evidence-that-has-reignited-the-debate-over-science-origins-and-the-existence-of-god-in-theatres-nationwide-from-fathom-entertainment-april-30-may-6-302703995.html

SOURCE Fathom Entertainment

FAQ

When will The Story of Everything play in theatres and when do tickets for AMC (NYSE:AMC) become available?

The film plays April 30–May 6, and tickets go on sale March 13, 2026. According to Fathom Entertainment, tickets will be sold via Fathom and participating theatre box offices, with locations subject to change, so check theatre listings early.

What is The Story of Everything about and who are the main contributors featured in the documentary?

The documentary advances arguments for Intelligent Design using cosmology and molecular biology evidence. According to Fathom Entertainment, contributors include Dr. Stephen C. Meyer, Jay W. Richards, Lee Strobel, John Lennox, and others presenting research and perspectives.

How is Fathom Entertainment related to AMC (NYSE:AMC) and could this theatrical release affect AMC's programming slate?

Fathom Entertainment is jointly owned by AMC, Cinemark, and Regal Cineworld Group. According to Fathom Entertainment, the release is a specialty theatrical engagement that aligns with Fathom's event distribution model and broadens content offerings for exhibitor partners.

Who produced The Story of Everything and what is the film's promotional timeline?

The film was produced by Brian Bird, Jason Pamer, and Jens Jacob with Executive Producer Lee Strobel. According to Fathom Entertainment, the trailer is released now, tickets on March 13, and theatrical engagements run April 30–May 6, 2026.

Will The Story of Everything be available beyond the April 30–May 6 theatrical window listed by Fathom Entertainment?

Initial engagements are scheduled for April 30–May 6 nationwide, with future availability not specified. According to Fathom Entertainment, tickets are initially offered through Fathom and participating theatres; further distribution depends on demand and exhibitor decisions.